Open Access

Amelioration of radiation-induced skin injury by adenovirus-mediated heme oxygenase-1 (HO-1) overexpression in rats

  • Shuyu Zhang1, 2, 5,
  • Chuanjun Song3,
  • Jundong Zhou1, 3,
  • Ling Xie3,
  • Xingjun Meng3,
  • Pengfei Liu4,
  • Jianping Cao1,
  • Xueguang Zhang1, 2,
  • Wei-Qun Ding5 and
  • Jinchang Wu3Email author
Contributed equally
Radiation Oncology20127:4

https://doi.org/10.1186/1748-717X-7-4

Received: 13 September 2011

Accepted: 17 January 2012

Published: 17 January 2012

Abstract

Objective

Radiation-induced skin injury remains a serious concern for radiation therapy. Heme oxygenase-1 (HO-1), the rate-limiting enzyme in heme catabolism, has been reported to have potential antioxidant and anti-apoptotic properties. However, the role of HO-1 in radiation-induced skin damage remains unclear. This study aims to elucidate the effects of HO-1 on radiation-induced skin injury in rats.

Methods

A control adenovirus (Ad-EGFP) and a recombinant adenovirus (Ad-HO1-EGFP) were constructed. Rats were irradiated to the buttock skin with a single dose of 45 Gy followed by a subcutaneous injection of PBS, 5 × 109 genomic copies of Ad-EGFP or Ad-HO1-EGFP (n = 8). After treatment, the skin MDA concentration, SOD activity and apoptosis were measured. The expression of antioxidant and pro-apoptotic genes was determined by RT-PCR and real-time PCR. Skin reactions were measured at regular intervals using the semi-quantitative skin injury score.

Results

Subcutaneous injection of Ad-HO1-EGFP infected both epidermal and dermal cells and could spread to the surrounding regions. Radiation exposure upregulated the transcription of the antioxidant enzyme genes, including SOD-1, GPx2 and endogenous HO-1. HO-1 overexpression decreased lipid peroxidation and inhibited the induction of ROS scavenging proteins. Moreover, HO-1 exerted an anti-apoptotic effect by suppressing FAS and FASL expression. Subcutaneous injection of Ad-HO1-EGFP demonstrated significant improvement in radiation-induced skin injury.

Conclusions

The present study provides evidences for the protective role of HO-1 in alleviating radiation-induced skin damage in rats, which is helpful for the development of therapy for radiation-induced skin injury.

Keywords

Radiation-induced skin injury HO-1 adenovirus lipid peroxidation apoptosis

Introduction

Radiotherapy offers valuable alternatives to primary surgical approaches for cancer patients. Despite being a useful modality for cancer therapy, ionizing radiation may injure surrounding normal tissues [1, 2]. Although the skin is not the primary target, it may be significantly injured and its function profoundly impaired during radiation therapy [3, 4]. While increased efforts have led to new treatment schedules that are designed to maximize antineoplastic effects and minimize skin toxicity, radiation-induced skin injury remains a serious concern, which may limit the duration of radiation and the dose delivered. In addition, nuclear accidents are another cause of such skin reactions [5, 6]. Thus, the management of radiation-induced skin damage is critical for effective radiation therapy.

During radiation exposure, skin tissue damage occurs instantaneously, mediated by a burst of free radicals. Irradiated cells produce reactive oxygen species (ROS), including oxygen ions, free radicals, and peroxides. The detrimental ROS can further result in damages to nuclear DNA and alterations of proteins, lipids, and carbohydrates [7]. In response to ionizing radiation exposure, signal transduction pathways, transcription factors, DNA repair enzymes and antioxidant enzymes are activated. Many of these signaling and gene expression pathways are involved in intracellular metabolic redox reactions to buffer the ROS [8]. Meanwhile, inflammatory cells are recruited and fibrogenesis and angiogenesis are initiated. High-dose ionizing radiation finally culminates in cutaneous cell death and profound impairment of skin function [4].

Heme oxygenases (HO) are microsomal enzymes that catalyse the heme ring into carbon monoxide (CO), free iron and biliverdin. Biliverdin is rapidly converted to bilirubin by biliverdin reductase. CO and bilirubin have been well described as having antioxidant and anti-inflammatory properties [9, 10]. The HO family consists of three homologous isoenzymes, an inducible HO-1, a constitutive HO-2 and an HO-3 with low enzymatic activity [11]. HO-1 is also known as heat shock protein 32 (HSP32), which is strongly induced by various stimuli including heat shock, metals, cytokines and oxidative stress [12, 13]. In the skin, the expression of HO-1 is strongly induced by ultraviolet radiation by the generation of biologically active phospholipid oxidation products. And its expression is most pronounced in the epidermal layers immediately below the stratum corneum [14]. HO-1 is also involved in skin immunity. Cutaneous inflammation was enhanced by HO-1 inhibition and was abrogated by treatment with the HO-1 inducer cobaltic protoporphyrin (CoPP) [15].

Since radiation exposure produces oxidative stress and consequently leads to skin injury, we reasoned that HO-1 overexpression would ameliorate the radiation-induced skin damage. In this study, we constructed a control adenovirus (Ad-EGFP) and a recombinant adenovirus (Ad-HO1-EGFP) that can overexpress rat HO-1. Subcutaneous injection of this Ad-HO1-EGFP infected cells in the epidermis and dermis, and ameliorated radiation-induced skin injury by reducing oxidative stress and suppressing apoptosis. These results will help the development of curative measures for radiation-induced skin injury.

Materials and methods

Construction of recombinant adenovirus

The rat HO-1 (GenBank accession no. NM012580) coding region was amplified by PCR using a pair of primers: (forward) 5'- ATGGAGCGCCCACAGCT-3' and (reverse) 5'- TTACATGGCATAAATTCCCACTG -3' and rat HO-1 cDNA. The coding region of the rat HO-1 gene was initially cloned into the pIRES2-EGFP vector, and the sequence of HO-1-IRES-EGFP was then subcloned into pShuttle-CMV. Adenoviruses expressing HO-1-IRES-EGFP and the control EGFP were generated using AdEasy™ Adenoviral Vector System (Agilent Technologies, Santa Clara, CA) per the manufacture's protocols. In brief, Shuttle plasmid DNA was linearized using PmeI, and treated with alkaline dephosphatase. The fragment was purified and recombined with pAdEasy-1 in BJ5183 cells. Positive clones were selected and transformed into XL10-Gold supercompetent E. coli cells. The confirmed recombinant adenovirus plasmids were each digested with PacI. Plasmids were then transfected into HEK-293A cells. Adenovirus expressing HO-1-IRES-EGFP or EGFP was propagated in HEK-293A cells and purified by CsCl gradients by ultracentrifugation. Titer of the viral solution was determined by Adeno-X Rapid Titer kit (Clontech, Mountain View, CA). These viruses were stored at -80°C prior to injection. Rats were given subcutaneous injection of Ad-EGFP or Ad-HO1-EGFP at an amount of 5 × 109 PFU suspended in 200 μl phosphate-buffered saline (PBS) after radiation exposure.

Animals and treatments

Male SD rats (4 weeks old) were purchased from Shanghai SLAC Laboratory Animal Co., Ltd. (Shanghai, China). Rats were anesthetized with an intraperitoneal injection of ketamine (75 mg/kg) and xylazine (10 mg/kg), and the hair on rat buttock skin was shaved using a razor. Rats were immobilized with adhesive tape on a plastic plate to minimize motion during irradiation exposure. A 3 cm thick pieces of lead was used to shield the rats and localize the radiation field (3 cm×4 cm). A single dose of 45 Gy was administered to the treatment area of each rat at a dose rate of 750 cGy/min using a 6-MeV electron beam accelerator (Clinac 2100EX; Varian Medical Systems Inc, CA). This dose was selected because it can significantly induce skin injury. After irradiation, rats were randomly divided into three groups: 1) rats were administered with a subcutaneous injection of 200-μl volume PBS; 2) with a subcutaneous injection of 5 × 109 genomic copies of Ad-EGFP in a 200-μl volume; 3) with a subcutaneous injection of 5 × 109 genomic copies of Ad-HO1-EGFP in a 200-μl volume. Skin reactions were followed at regular intervals using the semi-quantitative skin injury scale from 1 (no damage) to 5 (severe damage), as previously described [16]. All the protocols and procedures were approved by the Animal Experimentation Ethics Committee of the Soochow University.

Fluorescent Imaging of Ad-HO1-EGFP in vivo

Before injection, rats were anesthetized with an intraperitoneal injection of ketamine (75 mg/kg) and xylazine (10 mg/kg). A viral load of 5 × 109 genomic copies of Ad-HO1-EGFP (200 μl) or 200 μl of PBS was subcutaneously injected into buttocks of SD rats, respectively. To visualize infected cells, three days after the injection, the rats were anesthetized and imaged using a Kodak In-Vivo Multispectral Imaging System FX. Then, rats were sacrificed, frozen-cut sections of buttock skin were visualized under a fluorescent microscope.

Immunohistochemistry

Skin tissues were fixed in 10% neutral buffered formalin and later embedded in paraffin. Three micrometers thick paraffin sections were deparaffinized and heat treated with citrate buffer, pH 6.0, for 7 min following an epitope retrieval protocol. Endogenous peroxidase was blocked with 3% hydrogen peroxide for 15 min at room temperature, and tissue non-specific-binding sites were blocked with skimmed milk powder at 4% applied for 30 min. Sections were then incubated with the HO-1 antibody (Santa Cruz Biotechnology) for 1 h (dilution 1:200) and mixed with skimmed milk powder at 2% again to reduce unspecific staining. Biotinylated secondary antibody was then added for 30 min. Avidin-biotin-peroxidase complex (Dako LSAB2 system, DAKO Co., Carpinteria, CA) was added and color was developed using 3-3'-diaminobenzidine. Counterstaining was done with hematoxylin. All steps were performed at room temperature. Omitting the primary antibody from the procedure on the protocol was used as a negative control.

RNA extraction, reverse transcription- (RT)-PCR and real-time PCR

Total RNA from skin tissues was extracted with Trizol (Invitrogen, Carlsbad, CA) and reversely transcribed into cDNA using an oligo(dT)12 primer and the Superscript II reverse transcriptase (Invitrogen). SYBR green dye (Takara Bio Inc., Shiga, Japan) was used for amplification of cDNA. mRNA levels of SOD-1, endogenous HO-1, Catalase, GPx2, FAS, FASL and the internal standard β-Actin were measured by RT-PCR and real-time quantitative PCR in triplicate using a Prism 7500 real-time PCR machine (Applied Biosystems, Foster City, CA). The primer sequences were listed in Table 1.
Table 1

Primer sequences for RT-PCR and real-time PCR analysis

Gene

Forward primer

Reverse primer

Product size (bp)

β-Actin

5'- CCCATCTATGAGGGTTACGC -3'

5'- TTTAATGTCACGCACGATTTC -3'

150

endogenous HO-1

5'-CAGAAGGGTCAGGTGTCCAG-3'

5'- GAAGGCCATGTCCTGCTCTA -3'

262

SOD-1

5'- GCCAATGTGTCCATTGAAGA -3'

5'- CAATCACACCACAAGCCAAG -3'

168

CAT

5' - CACTGACGTCCACCCTGAC -3'

5'- GACTCCATCCAGCGATGATT -3'

242

GPx2

5' - CCTCGCTCTGAGGAACAACT-3'

5'- TGCCCATTGACATCACACTT -3'

220

FAS

5'- AGCTGCTCCAGTGCTGGTAT -3'

5'- CATAGGTGGCAGGCTCTCTC -3'

232

FASL

5'-AGACCACAAGGTCCAACAGG-3'

5'- CAAGTAGACCCACCCTGGAA-3'

244

Malondialdehyde (MDA) concentration measurement

After excision, fresh skin samples were homogenized with 50 mM phosphate buffer (pH 7.4). Then, homogenates were centrifuged at 12,000 × g for 10 min at 4°C. Supernatants were separated and kept at -20°C until MDA measurements were performed. Protein concentration supernatants were determined according to Lowry assay [17] using bovine serum albumin as a standard.

Tissue MDA levels were determined by thiobarbituric acid (TBA) reaction. The optical density (OD) was measured at a wavelength of 532 nm. The assay depended on the measurement of the pink color produced by the interaction of barbituric acid with MDA generated as a result of lipid peroxidation. The colored reaction with 1,1,3,3- tetraethoxy propane was used as the primary standard. The MDA levels were determined by the method of Yagi et al.[18]. MDA levels were expressed as a nanomol per milligram of protein (nmol/mg protein).

SOD activity measurement

Activity of SOD was measured using commercial available kit purchased from Nanjing Jiancheng BioEngineering (Nanjing, China). SOD activity measurement was based on the instructions of the colorimetric method.

Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay

Five μm skin sections were deparaffinized in xylene and hydrated in decreasing concentrations of ethanol, and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay was performed following manufacturer's instructions (Keygen, Nanjing, China). Ten random fields from 4 slides per group were examined. The TUNEL-positive brown nuclei within the skin were counted. The data were expressed as the mean number of apoptotic cells/high power field.

Statistical analysis

Data were expressed as the mean ± standard error of the mean (SEM) of at least three independent experiments. Standard error bars are included for all data points. The data were first analyzed with the Kolmogorov-Smirnov test for data distribution normality and then analyzed using Student's t test when only two groups were present, or assessed by one-way analysis of variance (ANOVA) when more than two groups were compared. For ordinal data, the Mann-Whitney test was used. Statistical analysis was performed using SPSS software (Release 17.0, SPSS Inc.). Data were considered significant if P < 0.05.

Results

The infection and expression of Ad-HO1-EGFP after its subcutaneous administration

To illustrate the therapeutic role of HO-1 in radiation-induced skin injury, a recombinant adenovirus (Ad-HO1-EGFP) and a control adenovirus (Ad-EGFP) were constructed (Figure 1A). To examine adenovirus mediated HO-1 gene expression and distribution in vivo, Ad-HO1-EGFP (5 × 109 genomic copies) was subcutaneously injected into buttocks of SD rats. After 3 days, EGFP gene expression was observed using a Kodark in vivo imaging system. Highly intensive EGFP expression was observed in the Ad-HO1-EGFP-injected buttock of SD rat, compared to the PBS-injected buttock. Interestingly, as shown in Figure 1B, fluorescence could be observed in the surrounding skin regions of the injection site (dotted circle), suggesting that Ad-HO1-EGFP could spread and infect surrounding skin cells. To further investigate the distribution of EGFP expression in skin tissues, frozen-cut sections of the buttock skin were observed under a microscope. As shown in Figure 1C, EGFP expression was observed in dermis of Ad-HO1-EGFP-injected rats, but not in that of the PBS-injected rats. Nevertheless, it is unclear whether Ad-HO1-EGFP infected the epidermis of rats because the stratum corneum displayed strong fluorescence, even in the control group. EGFP expression was found to persist for at least two weeks (data not shown). Immunohistochemistry was used to confirm the expression of HO-1 in rat skin tissues. As shown in Figure 1D, the expression of HO-1 was more pronounced in dermis (hair follicles and sebaceous glands) than in epidermis, 3 days after Ad-HO1-EGFP administration.
Figure 1

The distribution and expression of Ad-HO1-EGFP in rat skin. (A) Schematic diagram of the recombinant Ad-HO1-EGFP vector and the control vector (Ad-EGFP). (B) In vivo imaging of EGFP expression in SD rats. Rats were injected subcutaneously with 5 × 109 genomic copies of Ad-HO1-EGFP or equivalent volume of PBS. Three days after injection, the expression of EGFP was visualized. The dotted circle indicates the injection region. (C) The expression of EGFP was imaged from frozen-cut sections and observed under a fluorescent microscope (× 40). (D) Immunohistochemistry analysis of HO-1 expression in rat epidermis and dermis (× 200).

HO-1 overexpression decreased the production of MDA and the induction of antioxidant enzymes

Since radiation-induced ROS results in oxidative damage in lipids, DNA and proteins, cellular defenses have been proposed to play important roles in protecting the skin cells against oxidative stress and reducing the progression of skin injury [19, 20]. To test whether overexpression of HO-1 affects the radiation-induced lipid peroxidation, the concentration of MDA in the skin tissues after radiation with 45Gy was measured. As shown in Figure 2A, MDA levels were significantly decreased in tissues infected with Ad-HO1-EGFP, compared with the control group (P < 0.05), whereas infection of Ad-EGFP did not reduce the production of MDA. This indicated that HO-1 overexpression attenuates radiation-induced lipid peroxidation.
Figure 2

Quantitative analyses of MDA concentration, SOD activity and relative mRNA levels of the antioxidant enzyme genes. (A) Relative MDA concentration in rat skin tissues of indicated groups. (B) SOD activity in rat skin tissues of indicated groups. (C) Representative reverse transcription (RT)-PCR analysis of the antioxidant enzyme genes in indicated groups. (D) Real-time PCR analysis of the antioxidant enzyme genes in indicated groups (4 animals per group). mRNA levels are presented as means ± SEM (normalized to β-Actin). The men expression level in PBS-injected control group was arbitrarily set as 100%. * P < 0.05; ** P < 0.01, compared with PBS-injected control group.

A series of enzymes is involved in counteracting oxidative stress in cells, including superoxide dismutases (SOD), Catalase and Glutathione peroxidase (GPx). We found that 45Gy irradiation strongly upregulated mRNA expression of SOD-1, GPx2 and endogenous HO-1, and that overexpression of HO-1 significantly attenuated expression of these enzymes, compared with PBS-injected group (Figure 2B and 2C). Interestingly, radiation inactivated the expression of Catalase, relative to control skin tissues. The effect of HO-1 overexpression on SOD activity was also measured. Consistent with SOD-1 mRNA level, radiation increased the SOD activity, and Ad-HO1-EGFP injection counteracted this increase (Figure 2D). These results suggested that HO-1 overexpression significantly attenuates radiation-induced intracellular ROS accumulation, thereby reducing the need for skin cells to elicit an oxidant-induced response.

HO-1 overexpression inhibited the apoptosis of skin cells

To investigate the effect of HO-1 overexpression on cell apoptosis in the rat skin, we measured the mRNA levels of the key apoptosis-related genes. The cell death receptor Fas/CD95 and Fas/CD95 ligand (Fas-L) are complementary receptor-ligand proteins that initiate extrinsic apoptotic pathway [21]. After 45 Gy radiation, mRNA levels of FAS and FASL showed a marked elevation in skin tissues, suggesting an initiation of the apoptosis cascade. Administration of Ad-HO1-EGFP inhibited the expression of Fas and FASL, compared with the PBS- or Ad-EGFP-injected group (Figure 3A and 3B). Consistently, results from TUNEL assay showed significantly lower apoptotic cell death in Ad-HO1-EGFP treated group, compared with the PBS-treated rats (Figure 3C). These results indicated that HO-1 overexpression reduces radiation-induced apoptosis in skin cells.
Figure 3

Effects of HO-1 overexpression on radiation-induced skin cell apoptosis. (A) Representative RT-PCR analysis of the apoptosis pathway genes in rat skin tissues of indicated groups. (B) Real-time PCR analysis of the apoptosis pathway genes in indicated groups (4 animals per group). mRNA levels are presented as means ± SEM (normalized to β-Actin). The men expression level in PBS-injected control group was arbitrarily set as 100%. (C) Quantification of mean TUNEL-positive cells/per field are expressed as mean ± SD. * P < 0.05; ** P < 0.01, compared with PBS-injected control group.

HO-1-overexpression ameliorated radiation-induced skin injury

To determine whether adenovirus mediated HO-1 expression could attenuate radiation-induced skin injury, we performed an experiment using a single dose of 45 Gy delivered to the buttock skin of SD rats followed by a subcutaneous injection of Ad-EGFP or Ad-HO1-EGFP (5 × 109 genomic copies). The rats in the control group were injected with equivalent volume of PBS. Injuries of skin tissues were graded on a scale of 1 (no damage) to 5 (severe damage). Cutaneous damage was noticed 4 days after irradiation. Skin injury reached a maximum 15-18 days after irradiation, and then the skin wounds began to heal. Radiation-induced skin injury was significantly less severe in the Ad-HO1-EGFP-injected group, compared to the PBS-treated rats 19 days post irradiation, while the Ad-EGFP-administrated rats showed similar skin tissue damage with that of the control group (Figure 4).
Figure 4

Effect of HO-1 overexpression on the amelioration of radiation-induced skin injury. Rats were irradiated to the buttock skin with a single dose of 45 Gy followed by an injection of PBS, 5 × 109 genomic copies of Ad-EGFP or Ad-HO1-EGFP (8 animals per group). Skin injury in these groups was measured using a semi-quantitative score of 1 (no damage) to 5 (severe damage). * P < 0.05, compared with PBS-injected control group.

Discussions

There is increasing evidence indicating that HO-1 is involved in the pathogenesis of many diseases. HO-1 is a stress-responsive enzyme that can be induced by various oxidative agents and has recently emerged as a crucial mediator of antioxidant forces and tissue-protective actions. The physiological importance of HO-1 has been confirmed in HO-1 knockout-mice and in a HO-1-deficient human case, both of which showed a reduced cellular resistance to oxidative stress [2224]. Due to this documented protective activity of HO-1, we constructed an adenovirus construct that was used to overexpress HO-1 in rats aiming at testing its role in radiation-induced skin damage. We found that subcutaneous injection of the recombinant adenovirus ameliorates radiation-induced skin injury in rats most likely via suppression of oxidative stress and inhibition of cutaneous cell apoptosis.

Radiation exposure to tissues generates ROS and oxidative stress, which will trigger inflammatory response and cell death in affected areas. The ROS is known to oxidize fatty acids generating highly toxic lipid peroxides that lead to apoptotic cell death [25]. There is a well-established antioxidant enzyme system in eukaryotic cells which protects cells from oxidative damages. For instance, SOD is a primary antioxidant enzyme that converts superoxide to hydrogen peroxide, which can be subsequently detoxified into water and oxygen by catalase and GPx [26]. SOD-1 is the predominant form of three SOD enzymes, and GPx2 is a member of the selenium-containing antioxidative enzyme family, acting directly as an antioxidant and an inhibitor of lipid peroxidation [27]. In the present study, we demonstrated that injection of Ad-HO1-EGFP reduced radiation-induced skin MDA levels indicating that HO-1 attenuates radiation-induced lipid peroxidation. Furthermore, we found that radiation-induced expression of SOD-1, GPx2 and endogenous HO-1 was significantly down-regulated in tissues of the rats that were injected with Ad-HO1-EGFP. This suggests that HO-1 inhibits antioxidative responses from the skin cells to radiation insults. Note that overexpression of SOD-1 has been described to likely induce cell apoptosis [28], which may be associated with accumulation of toxic hydrogen peroxide produced by SOD that cannot be further detoxified by catalase and GPx. In this context, reduced SOD-1 expression supports a protection action of HO-1 on radiation-induced skin injury. However, radiation induced a suppression of catalase expression in our model system, which is in contrast to the expression of other antioxidant enzymes, and HO-1 over-expression had no effects on this suppression. A previous study by Chang et al. also reported that UVB radiation inhibited catalase activity in skin cells that was gradually recovered [29]. The underlying mechanisms for radiation-induced inactivation of catalase in skin cells merit further investigation. Taken together, these results indicate that overexpression of HO-1 attenuates oxidative stress and inhibits progression of skin injury.

Skin apoptosis is considered to be a vital indicator for skin injury [30]. The mechanisms by which apoptosis occurs in radiation-induced skin injury may provide an insight into the development of future radiation therapy. FAS and FASL serve as external pro-apoptotic sensors of cell damage and transmit the signal to the internal effectors. Accumulating evidence suggests that radiation-induced skin injury is mediated by Fas and FasL [3133]. We found that nonirradiated skin had little Fas and FasL expression; however, after electron beam exposure, the expression levels of Fas and FasL were strongly induced, which is in line with a previous report using ultraviolet radiation [31]. We demonstrated that radiation promoted apoptosis of rat cells in the epidermis and dermis using the TUNEL assay, and HO-1 overexpression resulted in a significant resistance to apoptosis, evidenced by a diminution of the TUNEL-positive cells. Thus, the alleviated damage in Ad-HO1-EGFP treated rats is likely due to less apoptosis of the skin cells. Suppression of apoptosis by HO-1 may contribute to alleviating the severity of skin injury induced by radiation.

In recent years, pharmacological interventions have been reported to reduce toxic radiation reactions. Pretreatment with caffeine, a major component of coffee, delays the progression of radiation-induced skin reactions, but cannot attenuate injury severity [34]. Essential fatty acids are shown to modulate normal tissue reactions to radiation damages [35]. It was reported that histone deacetylase (HDAC) inhibitors can suppress the aberrant expression of radiation-induced transforming growth factor β and tumor necrosis factor α and promote the healing of skin wounds [36]. In comparison, adenovirus-mediated gene transfer confers a long-term effect with high expression levels of the genes delivered and gene-specific activity. Since ROS are involved in radiation-induced injury, supplementations of antioxidant enzymes have been utilized to mitigate this injury. It is well known that detrimental superoxide anion, one of the major damaging ROS, can be converted to hydrogen peroxide by SOD. Yan et al. mitigated radiation-induced skin injury by AAV-mediated MnSOD (SOD2) expression using a mouse model [37]. MnSOD has also been shown to decrease superoxide levels and protect the bladder from radiation damage [38]. Our results indicate an alternative to SOD in the treatment of radiation-induced injury. Since HO-1 and SOD-1 exert their antioxidant actions via different cellular mechanisms, whether a combination of SOD and HO-1 delivery could be more effective in reducing radiation-induced skin damage warrants further exploration.

Conclusions

In summary, subcutaneous treatment with Ad-HO1-EGFP attenuated radiation-induced skin injury in rats via suppression of lipid peroxidation and apoptotic cell death. The present study provides evidences for the first time showing the protective role of HO-1 in radiation-induced skin injury in rats. This report contributes to our understanding of the therapeutic potential of HO-1 for radiation-induced skin injury.

Conflict of interest Statement

The authors declare that they have no competing interests.

Notes

Abbreviations

HO-1: 

heme oxygenase-1

EGFP: 

enhanced green fluorescent protein

RT-PCR: 

reverse transcription-polymerase chain reaction

MDA: 

malondialdehyde

SOD: 

superoxide dismutases

GPx: 

Glutathione peroxidase

MDA: 

malondialdehyde

Declarations

Acknowledgements

This work is supported by the National Natural Science Foundation of China (81102078 and 81172597), National Defense Basic Research Project (B3820110002), the Research Foundation of Health Agency of Jiangsu Province (H200837), Program for Changjiang Scholars and Innovative Research Team in University (IRT0849) and Suzhou Social Development foundation (SYS201046). We thank Min Liu for assistance in the experiments.

Authors’ Affiliations

(1)
School of Radiation Medicine and Protection, Medical College of Soochow University
(2)
Cultivation base of State Key Laboratory of Stem Cell and Biomaterials built together by Ministry of Science and Technology and Jiangsu Province, Soochow University
(3)
The Core Laboratory of Suzhou Cancer Center and Department of Radiotherapy of Suzhou Hospital Affiliated to Nanjing Medical University
(4)
Department of Gastroenterology, the Affiliated Jiangyin Hospital of Southeast University
(5)
Department of Pathology, University of Oklahoma Health Sciences Center

References

  1. Huber R, Braselmann H, Geinitz H, Jaehnert I, Baumgartner A, Thamm R, Figel M, Molls M, Zitzelsberger H: Chromosomal radiosensitivity and acute radiation side effects after radiotherapy in tumour patients--a follow-up study. Radiat Oncol 2011, 6: 32. 10.1186/1748-717X-6-32PubMed CentralView ArticlePubMedGoogle Scholar
  2. Sprung CN, Chao M, Leong T, McKay MJ: Chromosomal radiosensitivity in two cell lineages derived from clinically radiosensitive cancer patients. Clin Cancer Res 2005, 11: 6352-6358. 10.1158/1078-0432.CCR-04-1931View ArticlePubMedGoogle Scholar
  3. Simonen P, Hamilton C, Ferguson S, Ostwald P, O'Brien M, O'Brien P, Back M, Denham J: Do inflammatory processes contribute to radiation induced erythema observed in the skin of humans? Radiother Oncol 1998, 46: 73-82. 10.1016/S0167-8140(97)00115-1View ArticlePubMedGoogle Scholar
  4. Hymes SR, Strom EA, Fife C: Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 2006, 54: 28-46. 10.1016/j.jaad.2005.08.054View ArticlePubMedGoogle Scholar
  5. Gottlober P, Bezold G, Weber L, Gourmelon P, Cosset JM, Bahren W, Hald HJ, Fliedner TM, Peter RU: The radiation accident in Georgia: clinical appearance and diagnosis of cutaneous radiation syndrome. J Am Acad Dermatol 2000, 42: 453-458. 10.1016/S0190-9622(00)90218-4View ArticlePubMedGoogle Scholar
  6. Hoashi T, Okochi H, Kadono T, Tamaki K, Nishida M, Futami S, Maekawa K: A case of acute radiation syndrome from the dermatological aspect. Br J Dermatol 2008, 158: 597-602. 10.1111/j.0007-0963.2007.08306.xView ArticlePubMedGoogle Scholar
  7. Watters D: Molecular mechanisms of ionizing radiation-induced apoptosis. Immunol Cell Biol 1999, 77: 263-271. 10.1046/j.1440-1711.1999.00824.xView ArticlePubMedGoogle Scholar
  8. Spitz DR, Azzam EI, Li JJ, Gius D: Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev 2004, 23: 311-322.View ArticlePubMedGoogle Scholar
  9. Immenschuh S, Ramadori G: Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol 2000, 60: 1121-1128. 10.1016/S0006-2952(00)00443-3View ArticlePubMedGoogle Scholar
  10. Ryter SW, Alam J, Choi AM: Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006, 86: 583-650. 10.1152/physrev.00011.2005View ArticlePubMedGoogle Scholar
  11. Elbirt KK, Bonkovsky HL: Heme oxygenase: recent advances in understanding its regulation and role. Proc Assoc Am Physicians 1999, 111: 438-447.PubMedGoogle Scholar
  12. Lee TS, Chau LY: Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002, 8: 240-246. 10.1038/nm0302-240View ArticlePubMedGoogle Scholar
  13. Shan Y, Pepe J, Lu TH, Elbirt KK, Lambrecht RW, Bonkovsky HL: Induction of the heme oxygenase-1 gene by metalloporphyrins. Arch Biochem Biophys 2000, 380: 219-227. 10.1006/abbi.2000.1921View ArticlePubMedGoogle Scholar
  14. Gruber F, Oskolkova O, Leitner A, Mildner M, Mlitz V, Lengauer B, Kadl A, Mrass P, Kronke G, Binder BR, Bochkov VN, Leitinger N, Tschachler E: Photooxidation generates biologically active phospholipids that induce heme oxygenase-1 in skin cells. J Biol Chem 2007, 282: 16934-16941. 10.1074/jbc.M702523200View ArticlePubMedGoogle Scholar
  15. Listopad J, Asadullah K, Sievers C, Ritter T, Meisel C, Sabat R, Docke WD: Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells. Exp Dermatol 2007, 16: 661-670. 10.1111/j.1600-0625.2007.00581.xView ArticlePubMedGoogle Scholar
  16. Kohl RR, Kolozsvary A, Brown SL, Zhu G, Kim JH: Differential radiation effect in tumor and normal tissue after treatment with ramipril, an angiotensin-converting enzyme inhibitor. Radiat Res 2007, 168: 440-445. 10.1667/RR0707.1View ArticlePubMedGoogle Scholar
  17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193: 265-275.PubMedGoogle Scholar
  18. Yagi K: Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods Mol Biol 1998, 108: 107-110.PubMedGoogle Scholar
  19. Girotti AW: Photosensitized oxidation of membrane lipids: reaction pathways, cytotoxic effects, and cytoprotective mechanisms. J Photochem Photobiol B 2001, 63: 103-113. 10.1016/S1011-1344(01)00207-XView ArticlePubMedGoogle Scholar
  20. Moulder JE: Pharmacological intervention to prevent or ameliorate chronic radiation injuries. Semin Radiat Oncol 2003, 13: 73-84. 10.1053/srao.2003.50007View ArticlePubMedGoogle Scholar
  21. Yamamoto T, Nishioka K: Possible role of apoptosis in the pathogenesis of bleomycin-induced scleroderma. J Invest Dermatol 2004, 122: 44-50. 10.1046/j.0022-202X.2003.22121.xView ArticlePubMedGoogle Scholar
  22. Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, Agarwal A: Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol 2004, 165: 1045-1053. 10.1016/S0002-9440(10)63365-2PubMed CentralView ArticlePubMedGoogle Scholar
  23. Wiesel P, Patel AP, DiFonzo N, Marria PB, Sim CU, Pellacani A, Maemura K, LeBlanc BW, Marino K, Doerschuk CM, Yet SF, Lee ME, Perrella MA: Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation 2000, 102: 3015-3022.View ArticlePubMedGoogle Scholar
  24. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999, 103: 129-135. 10.1172/JCI4165PubMed CentralView ArticlePubMedGoogle Scholar
  25. Xu H, Yan Y, Li L, Peng S, Qu T, Wang B: Ultraviolet B-induced apoptosis of human skin fibroblasts involves activation of caspase-8 and -3 with increased expression of vimentin. Photodermatol Photoimmunol Photomed 2010, 26: 198-204. 10.1111/j.1600-0781.2010.00522.xView ArticlePubMedGoogle Scholar
  26. Dreher F, Maibach H: Protective effects of topical antioxidants in humans. Curr Probl Dermatol 2001, 29: 157-164.View ArticlePubMedGoogle Scholar
  27. Pugliese PT: The skin's antioxidant systems. Dermatol Nurs 1998, 10: 401-416. quiz 417-408PubMedGoogle Scholar
  28. Pahlavani MA, Mele JF, Richardson A: Effect of overexpression of human Cu/Zn-SOD on activation-induced lymphocyte proliferation and apoptosis. Free Radic Biol Med 2001, 30: 1319-1327. 10.1016/S0891-5849(01)00529-9View ArticlePubMedGoogle Scholar
  29. Chang C, Zheng R: Effects of ultraviolet B on epidermal morphology, shedding, lipid peroxide, and antioxidant enzymes in Cope's rat snake (Elaphe taeniura). J Photochem Photobiol B 2003, 72: 79-85. 10.1016/j.jphotobiol.2003.06.001View ArticlePubMedGoogle Scholar
  30. Suarez-Penaranda JM, Rodriguez-Calvo MS, Ortiz-Rey JA, Munoz JI, Sanchez-Pintos P, Da Silva EA, De la Fuente-Buceta A, Concheiro-Carro L: Demonstration of apoptosis in human skin injuries as an indicator of vital reaction. Int J Legal Med 2002, 116: 109-112. 10.1007/s00414-001-0278-3View ArticlePubMedGoogle Scholar
  31. Hill LL, Ouhtit A, Loughlin SM, Kripke ML, Ananthaswamy HN, Owen-Schaub LB: Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science 1999, 285: 898-900. 10.1126/science.285.5429.898View ArticlePubMedGoogle Scholar
  32. Chow J, Tron VA: Molecular aspects of ultraviolet radiation-induced apoptosis in the skin. J Cutan Med Surg 2005, 9: 289-295. 10.1007/s10227-005-0109-0View ArticlePubMedGoogle Scholar
  33. Bang B, Rygaard J, Baadsgaard O, Skov L: Increased expression of Fas on human epidermal cells after in vivo exposure to single-dose ultraviolet (UV) B or long-wave UVA radiation. Br J Dermatol 2002, 147: 1199-1206. 10.1046/j.1365-2133.2002.04787.xView ArticlePubMedGoogle Scholar
  34. Hebbar SA, Mitra AK, George KC, Verma NC: Caffeine ameliorates radiation-induced skin reactions in mice but does not influence tumour radiation response. J Radiol Prot 2002, 22: 63-69. 10.1088/0952-4746/22/1/306View ArticlePubMedGoogle Scholar
  35. Hopewell JW, van den Aardweg GJ, Morris GM, Rezvani M, Robbins ME, Ross GA, Whitehouse EM, Scott CA, Horrobin DF: Amelioration of both early and late radiation-induced damage to pig skin by essential fatty acids. Int J Radiat Oncol Biol Phys 1994, 30: 1119-1125.View ArticlePubMedGoogle Scholar
  36. Chung YL, Wang AJ, Yao LF: Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy. Mol Cancer Ther 2004, 3: 317-325. 10.4161/cbt.3.3.698View ArticlePubMedGoogle Scholar
  37. Yan S, Brown SL, Kolozsvary A, Freytag SO, Lu M, Kim JH: Mitigation of radiation-induced skin injury by AAV2-mediated MnSOD gene therapy. J Gene Med 2008, 10: 1012-1018. 10.1002/jgm.1226View ArticlePubMedGoogle Scholar
  38. Kanai AJ, Zeidel ML, Lavelle JP, Greenberger JS, Birder LA, de Groat WC, Apodaca GL, Meyers SA, Ramage R, Epperly MW: Manganese superoxide dismutase gene therapy protects against irradiation-induced cystitis. Am J Physiol Renal Physiol 2002, 283: F1304-1312.View ArticlePubMedGoogle Scholar

Copyright

© Zhang et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.